Product/Composition:- | Diclofenac tablets |
---|---|
Strength:- | 25 mg, 50 mg, 75 mg, 100 mg |
Form:- | Tablets |
Reference Brands:- | Voltaren(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Diclofenac inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, which alleviates pain, inflammation, and fever. Benefits include effective relief of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions, offering rapid pain reduction, improved joint function, and a well-established safety profile when used appropriately.
iclofenac tablets are approved in the EU and US for pain, inflammation, and rheumatoid arthritis. In the EU, brands like Voltaren and Cataflam are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for diclofenac tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy, helping you meet regulatory requirements seamlessly.